Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
BELITE BIO INC - ADR
About BLTE
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company. The Company is focused on advancing novel therapeutics targeting retinal degenerative eye disease, such as Geographic Atrophy (GA), age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1), both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout. Its lead product candidate, Tinlarebant, is an oral daily treatment for STGD1 and GA patients. In STGD1, it is developing Tinlarebant as a once-a-day tablet treatment to target Retinol binding protein 4 (RBP4) by disrupting vitamin A (retinol) binding to RBP4, which leads to reduced delivery of retinol to the eye and reduced accumulation of toxic vitamin A by-products. Its product candidate also includes LBS-009, an anti-RBP4 oral therapy targeting liver disease, including NAFLD, NASH, and T2D.
Find out what a historical investment in BELITE BIO INC - ADR would be worth today using our BLTE stock calculator.
Market Capitalisation
$5.69B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
97.68K
High today
$143.38
Low today
$139.82
Open price
$141.53
52-week high
$200.00
52-week low
$56.10
Ready to start your investing journey with Stake?
Open an accountHow do I buy BLTE shares in Australia?
Buying BLTE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BELITE BIO INC - ADR in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BLTE
What is the ticker symbol of BELITE BIO INC - ADR?
The ticker symbol for BELITE BIO INC - ADR is BLTE.
How much is one share of BLTE?
One share of BLTE is valued at $143.17 as of 27 May 2026.
What is the market capitalisation of BELITE BIO INC - ADR BLTE?
As of 27 May 2026 BELITE BIO INC - ADR has a market cap of $5.69B.
What is the 52-week high for BELITE BIO INC - ADR stock?
The BELITE BIO INC - ADR 52-week high stock price is $200.00.
What is the 52-week low for BELITE BIO INC - ADR stock?
The BELITE BIO INC - ADR 52-week low stock price is $56.10.
Can I buy BLTE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BLTE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BLTE on Stake
- Buy BLTE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of BLTE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BLTE related stocks